Taipale, Heidi, et al. "20‐year follow‐up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)." World psychiatry 19.1 (2020): 61-68.
SUMMARY AND MULTIPLE CHOICE Questions by OPENAI
The article is a retrospective cohort study that examines the association between antipsychotic use and mortality in patients with schizophrenia. The study finds that antipsychotic use is associated with lower all-cause, cardiovascular, and suicide mortality compared with non-use, and clozapine is associated with the most beneficial mortality outcome. LAI fluphenazine in monotherapy was associated with a significantly decreased risk of cardiovascular hospitalization. Specific antipsychotics were associated with a lower risk of death, and several antipsychotics were associated with a reduced suicide mortality.